Core Viewpoint - The stock of United Imaging Healthcare (688271) has shown a positive performance with a closing price of 131.1 yuan, reflecting a 2.41% increase as of January 29, 2026, with significant trading activity and capital flow dynamics [1]. Financial Performance - For the first three quarters of 2025, United Imaging Healthcare reported a main revenue of 8.859 billion yuan, representing a year-on-year increase of 27.39% [3]. - The net profit attributable to shareholders reached 1.12 billion yuan, up 66.91% year-on-year, while the net profit excluding non-recurring items was 1.053 billion yuan, marking a 126.94% increase [3]. - In Q3 2025 alone, the company achieved a main revenue of 2.843 billion yuan, a significant year-on-year increase of 75.41%, and a net profit of 122 million yuan, which is up 143.8% year-on-year [3]. - The company's gross profit margin stands at 47.02%, with a debt ratio of 30.08% and investment income of 606.847 million yuan [3]. Market Activity - On January 29, 2026, the stock experienced a net inflow of 41.0225 million yuan from institutional investors, accounting for 3.38% of the total trading volume, while retail investors saw a net outflow of 1.2636 million yuan [1]. - The financing data indicates that on the same day, the financing buy amounted to 989.752 million yuan, with a net repayment of 514.792 million yuan [2]. - The total balance of margin financing and securities lending stands at 1.479 billion yuan [2]. Analyst Ratings - Over the past 90 days, 21 institutions have provided ratings for United Imaging Healthcare, with 15 buy ratings and 6 hold ratings, indicating a generally positive outlook [3]. - The average target price set by institutions for the stock over the last 90 days is 176.65 yuan [3].
联影医疗(688271)1月29日主力资金净买入4102.25万元